Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.
scientific article
Author/s
author: Larry Norton, Hyman B Muss, Gretchen G Kimmick, Ruth M O'Regan, Edith A. Perez, Constance T Cirrincione, Lawrence N Shulman, Clifford A Hudis, Eric Winer, Donald H Berry, Heather P Becker, Silvana Martino, Erica L Mayer
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.